Background Over the past two decades, considerable biomedical successes have been
achieved in the science of prevention of mother‐to‐child transmission of HIV (PMTCT) in sub‐
Saharan Africa. Effective interventions that can significantly reduce in utero, intra‐partum
and postnatal HIV transmission are now available [1–3]. Despite the increasing availability
of antiretroviral drugs for PMTCT and the international mobilization for the implementation of
these services, the escalation of PMTCT interventions in many countries in Africa has proved …